It’s possible, approvals on far less compelling recent studies. Look at SRPTs DMD approval. The FDA statistician thought they didn’t prove anything on a 12 patients. But no treatment available and patients parents brow beat FDA Director into an approval. I think P doesn’t need a PIII trial either. IMO
(4)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links